<code id='683D558072'></code><style id='683D558072'></style>
    • <acronym id='683D558072'></acronym>
      <center id='683D558072'><center id='683D558072'><tfoot id='683D558072'></tfoot></center><abbr id='683D558072'><dir id='683D558072'><tfoot id='683D558072'></tfoot><noframes id='683D558072'>

    • <optgroup id='683D558072'><strike id='683D558072'><sup id='683D558072'></sup></strike><code id='683D558072'></code></optgroup>
        1. <b id='683D558072'><label id='683D558072'><select id='683D558072'><dt id='683D558072'><span id='683D558072'></span></dt></select></label></b><u id='683D558072'></u>
          <i id='683D558072'><strike id='683D558072'><tt id='683D558072'><pre id='683D558072'></pre></tt></strike></i>

          Home / entertainment / entertainment

          entertainment


          entertainment

          author:hotspot    Page View:7933
          A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT
          Adobe

          The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

          Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

          advertisement

          Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In